438 related articles for article (PubMed ID: 7887634)
1. [Progress of chemotherapy in adult acute leukemia].
Ohno R
Gan To Kagaku Ryoho; 1995 Mar; 22(4):431-6. PubMed ID: 7887634
[TBL] [Abstract][Full Text] [Related]
2. [Progress in the treatment of adult acute myeloid leukemia].
Ohno R
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1053-8. PubMed ID: 9239156
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of 58 patients with acute leukemia].
Sasaki A; Tsukaguchi M
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1303-7. PubMed ID: 1503484
[TBL] [Abstract][Full Text] [Related]
4. [Progress in the treatment of acute myelogenous leukemia].
Dohy H; Kyo T
Gan To Kagaku Ryoho; 1989 May; 16(5):1976-81. PubMed ID: 2658836
[TBL] [Abstract][Full Text] [Related]
5. [Recent advances on the treatment of acute childhood leukemia].
Fujimoto T
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1059-65. PubMed ID: 9239157
[TBL] [Abstract][Full Text] [Related]
6. Aggressive chemotherapy for acute leukemia relapsed after bone marrow transplantation: a second chance?
Sica S; Di Mario A; Pagano L; Etuk B; Salutari P; Leone G
Acta Haematol; 1992; 87(4):173-5. PubMed ID: 1519431
[TBL] [Abstract][Full Text] [Related]
7. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group.
Amadori S; Testi AM; Aricò M; Comelli A; Giuliano M; Madon E; Masera G; Rondelli R; Zanesco L; Mandelli F
J Clin Oncol; 1993 Jun; 11(6):1046-54. PubMed ID: 8501490
[TBL] [Abstract][Full Text] [Related]
8. [Cancer curable by chemotherapy: acute myelogenous leukemia].
Ohno R; Tanimoto M; Morishita Y; Morishima Y; Saito H; Yokomaku S; Nagai T; Kodera Y; Minami S
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1329-34. PubMed ID: 2730046
[TBL] [Abstract][Full Text] [Related]
9. [Retrospective analysis of elderly patients > or = 60 years of age with acute leukemia].
Tabata M; Yoshida M; Izumi T; Kawano C; Kuribara R; Toshima M; Omine K; Takatoku M; Uchida M; Kirito K; Miyazato A; Takahashi H; Hoshino M; Terui Y; Tomizuka H; Otsuki T; Shimizu R; Tsunoda J; Muroi K; Furukawa Y; Amemiya Y; Imagawa S; Komatsu N; Suzuki T; Miura Y
Rinsho Ketsueki; 1998 Mar; 39(3):176-84. PubMed ID: 9577640
[TBL] [Abstract][Full Text] [Related]
10. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group.
Kobayashi T; Miyawaki S; Tanimoto M; Kuriyama K; Murakami H; Yoshida M; Minami S; Minato K; Tsubaki K; Ohmoto E; Oh H; Jinnai I; Sakamaki H; Hiraoka A; Kanamaru A; Takahashi I; Saito K; Naoe T; Yamada O; Asou N; Kageyama S; Emi N; Matsuoka A; Tomonaga M; Ohno R
J Clin Oncol; 1996 Jan; 14(1):204-13. PubMed ID: 8558199
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of conventional chemotherapy and short-term intensive chemotherapy in adult acute myeloid leukemia].
Ohshima T
Rinsho Ketsueki; 1989 Aug; 30(8):1175-7. PubMed ID: 2601028
[TBL] [Abstract][Full Text] [Related]
12. [Short-term intensive consolidation chemotherapy in the treatment of acute non-lymphocytic leukemia].
Nagata K; Hatanaka T; Ito T; Saito M; Ono Y; Kamiya O; Ohara K
Gan To Kagaku Ryoho; 1992 Jul; 19(7):1079-81. PubMed ID: 1626944
[No Abstract] [Full Text] [Related]
13. Treatment of acute non-lymphocytic leukemia with alternating non-cross resistant chemotherapy.
Kyo T; Dohy H
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1641-52. PubMed ID: 3247827
[No Abstract] [Full Text] [Related]
14. Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.
De Astis E; Clavio M; Raiola AM; Ghiso A; Guolo F; Minetto P; Galaverna F; Miglino M; Di Grazia C; Ballerini F; Marani C; Pastori G; Mitscheunig L; Cruciani F; Lovera D; Varaldo R; Ghiggi C; Lemoli RM; Bacigalupo A; Gobbi M
Ann Hematol; 2014 Dec; 93(12):2011-8. PubMed ID: 24989345
[TBL] [Abstract][Full Text] [Related]
15. [Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia].
Taguchi H; Kubonishi I; Takehara N; Uemura Y; Iwahara Y; Eguchi T; Miyagi T; Sugito S; Muneishi H; Tanaka Y
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1309-14. PubMed ID: 1503485
[TBL] [Abstract][Full Text] [Related]
16. Aggressive chemotherapy for acute leukemia relapsed after transplantation.
Sica S; Salutari P; Di Mario A; D'Onofrio G; Etuk B; Leone G
Leuk Lymphoma; 1994 Sep; 15(1-2):131-4. PubMed ID: 7858490
[TBL] [Abstract][Full Text] [Related]
17. Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG).
Ohno R; Kobayashi T; Morishima Y; Hiraoka A; Imai K; Asoh N; Tsubaki K; Tomonaga M; Takahashi I; Kodera K
Leukemia; 1992; 6 Suppl 2():92-5. PubMed ID: 1578954
[TBL] [Abstract][Full Text] [Related]
18. Therapy of acute myelogenous leukemia: results of combination chemotherapy with cytarabine, daunorubicin and 6-mercaptopurine.
Ko WS; Chen LM; Hwang SH; Chao TY; Wang CC; Kao WY; Lee WC; Hwang WS
Zhonghua Yi Xue Za Zhi (Taipei); 1991 Sep; 48(3):185-9. PubMed ID: 1657335
[TBL] [Abstract][Full Text] [Related]
19. Association between the secondary colony-plating efficiency of blast progenitors and the remission induction outcome of acute myeloblastic leukemia patients.
Nara N
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1624-9. PubMed ID: 3247826
[No Abstract] [Full Text] [Related]
20. Improved survival for patients with acute myelogenous leukemia.
Mitus AJ; Miller KB; Schenkein DP; Ryan HF; Parsons SK; Wheeler C; Antin JH
J Clin Oncol; 1995 Mar; 13(3):560-9. PubMed ID: 7884416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
